Zangyu Pan

No ORCID on file · 9 papers in corpus · active 2022-2024

Study types

  • article 7
  • other 1
  • preprint 1

Condition tags

  • adenomyosis 6
  • dysmenorrhea 3
  • mesh:D004715 3
  • endometriosis 3
  • mesh:D004412 3
  • mesh:D017699 1
article 2024
Frontiers in endocrinology ·doi:10.3389/fendo.2024.1371393

Background and Aims The association of the triglyceride-glucose (TyG) index, a promising novel biomarker for insulin resistance, with the risk of endometriosis has not been investigated to date. This nationwide study aimed to explore the as…

article 2024
Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology ·doi:10.1080/09513590.2024.2409918

OBJECTIVE: We carried out this study to explore the possibility of initiating goserelin therapy during the non-menstrual period in patients diagnosed with adenomyosis. METHODS: 115 premenopausal adenomyosis patients were enrolled and divide…

article 2024
BMC microbiology ·doi:10.1186/s12866-024-03339-9

BACKGROUND: Adenomyosis is a commonly observed benign gynecological disease that affects the quality of life and social psychology of women of childbearing age. However, because of the unknown etiology and incidence of adenomyosis, its path…

article 2023
Reproductive biology and endocrinology : RB&E ·doi:10.1186/s12958-023-01145-y

BACKGROUND: To determine whether there is a correlation between stiffness measured by strain elastography and the severity of dysmenorrhea and to determine the value of elastography in evaluating severe dysmenorrhea in patients with adenomy…

article 2023
Journal of psychosomatic obstetrics and gynaecology ·doi:10.1080/0167482x.2023.2214842

The management of endometriosis has been complicated by the COVID-19 pandemic. We aimed to introduce the establishment and application of a new follow-up method during the COVID-19 pandemic—the electronic follow-up (e-follow-up) platform fo…

article 2023
Reproductive biomedicine online ·doi:10.1016/j.rbmo.2023.05.003
preprint 2023
·doi:10.21203/rs.3.rs-3317589/v1
other 2022
Journal of clinical medicine ·doi:10.3390/jcm11185286

The absence of clinically objective methods to evaluate adenomyosis-associated pain and the poor understanding of its pathophysiology lead to treatment limitations. We conducted a resting-state functional magnetic resonance imaging study wi…

article 2022
Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology ·doi:10.1080/09513590.2022.2160435

OBJECTIVE: This prospective cohort study aimed to compare the clinical efficacy and safety of goserelin 10.8 mg administered trimonthly with goserelin 3.6 mg administered monthly in premenopausal females with symptomatic adenomyosis. METHOD…